Vascular target organ damage in patients with Philadelphia negative myeloproliferative syndrome: A propensity score analysis

Med Clin (Barc). 2022 Jun 10;158(11):503-508. doi: 10.1016/j.medcli.2021.05.024. Epub 2021 Aug 13.
[Article in English, Spanish]

Abstract

Purpose: To assess whether subjects with Philadelphia negative myeloproliferative neoplasms (Ph-MPNs) show differences in the presence of vascular, cardiac or renal target organ damage (TOD) and other vascular function parameters as compared to individuals without this condition.

Methods: An observational study was conducted. Fifty-seven subjects diagnosed with Ph-MPNs used as cases and 114 subjects without Ph-MPNs as controls. We matched the subjects with and without Ph-MPNs using the propensity scores in a 1:2 ratio using the variables gender, type 2 diabetes mellitus, high blood pressure, hyperlipidaemia and smoking. Vascular, cardiac and renal TOD were established according to the criteria of the European Society of Hypertension and Cardiology guidelines. Arterial stiffness was also assessed using the cardio-ankle vascular index (CAVI).

Results: Mean age was 63.50±11.70 and 62.90±8.32 years in subjects with and without Ph-MPNs, 32 females (56%) in the first group and 62 (54%) in the second. Subjects with Ph-MPNs have a higher percentage of carotid injury than subjects without Ph-MPNs (35.1% vs. 21.1%) and higher albumin/creatinine ratio. In the logistic regression analysis, subjects with Ph-MPNs had an OR=2.382 (IC95% 1.066-5.323) for carotid injury versus those without haematological disease.

Conclusions: Subjects with Ph-MPNs have twice the risk of by carotid injury than those without haematological disease.

Keywords: Arterial stiffness; Essential thrombocythemia; Lesión de órgano diana; Policitemia vera; Polycythemia vera; Rigidez arterial; Target organ damage; Trombocitemia esencial.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Diabetes Mellitus, Type 2*
  • Female
  • Humans
  • Middle Aged
  • Myeloproliferative Disorders* / complications
  • Myeloproliferative Disorders* / diagnosis
  • Propensity Score
  • Vascular Stiffness*